Tuberculosis Preventive Therapy among Persons Living with HIV, Uganda, 2016-2022

被引：4

作者：

Lukoye, Deus ^{[1
,6
]}

Gustavson, Gail ^{[1
]}

Namuwenge, Proscovia M. ^{[2
]}

Muchuro, Simon ^{[2
]}

Birabwa, Estella ^{[3
]}

Dejene, Seyoum ^{[4
]}

Ssempiira, Julius ^{[1
]}

Kalamya, Julius N. ^{[1
]}

Baveewo, Steven ^{[1
]}

Ferroussier-Davis, Odile ^{[5
]}

Mills, Lisa A. ^{[1
]}

Dirlikov, Emilio ^{[1
]}

Nelson, Lisa J. ^{[1
]}

Turyahabwe, Stavia ^{[2
]}

机构：

[1] US Ctr Dis Control & Prevent, Kampala, Uganda

[2] Uganda Minist Hlth, Kampala, Uganda

[3] US Dept Def, Kampala, Uganda

[4] US Agcy Int Dev, Kampala, Uganda

[5] US Ctr Dis Control & Prevent, Atlanta, GA USA

[6] US Embassy, US Ctr Dis Control & Prevent Uganda, 1577 Ggaba Rd,Nsambya,POB 7007, Kampala, Uganda

来源：

EMERGING INFECTIOUS DISEASES | 2023年 / 29卷 / 03期

关键词：

SCALE-UP;

D O I：

10.3201/eid2903.221353

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

During October 2016-March 2022, Uganda increased tuberculosis (TB) preventive therapy coverage among persons living with HIV from 0.6% to 88.8%. TB notifi-cation rates increased from 881.1 to 972.5 per 100,000 persons living with HIV. Timely TB screening, diagnosis, and earlier treatment should remain high priorities for TB/HIV prevention programming.

引用

页码：609 / 613

页数：5

共 50 条

[31] Tuberculosis preventive therapy in HIV-infected persons: feasibility issues in developing countries
Hawken, MP
Muhindi, DW
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (08) : 646 - 650
[32] PREVENTIVE THERAPY FOR TUBERCULOSIS IN HIV-INFECTED PERSONS - INTERNATIONAL RECOMMENDATIONS, RESEARCH, AND PRACTICE
DECOCK, KM
GRANT, A
PORTER, JDH
LANCET, 1995, 345 (8953): : 833 - 836
[33] Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study
Henok Tadesse Ayele
Maaike SM van Mourik
Marc JM Bonten
BMC Infectious Diseases, 15
[34] Safety and tolerability of isoniazid preventive therapy for tuberculosis for persons with HIV with and without alcohol use
Hahn, Judith A.
Ngabirano, Christine
Fatch, Robin
Emenyonu, Nneka I.
Cheng, Debbie M.
Adong, Julian
Tumwegamire, Adah
Terrault, Norah A.
Linas, Benjamin P.
Jacobson, Karen R.
Muyindike, Winnie R.
AIDS, 2023, 37 (10) : 1535 - 1543
[35] Preferences of people living with HIV for features of tuberculosis preventive treatment regimens in Uganda: a discrete choice experiment
Aschmann, Helene E.
Musinguzi, Allan
Kadota, Jillian L.
Namale, Catherine
Kakeeto, Juliet
Nakimuli, Jane
Akello, Lydia
Welishe, Fred
Nakitende, Anne
Berger, Christopher
Dowdy, David W.
Cattamanchi, Adithya
Semitala, Fred C.
Kerkhoff, Andrew D.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 (12)
[36] Preventive therapy for tuberculosis in HIV infection
Brewer, TF
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (10): : 881 - 882
[37] Promoting tuberculosis preventive therapy in HIV
LaCourse, Sylvia M.
Onyango, Dickens
LANCET HIV, 2022, 9 (09): : E596 - E597
[38] Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues
Kumar, A.
Kumar, A. M. V.
Gupta, D.
Kanchar, A.
Mohammed, S.
Srinath, S.
Tripathy, S.
Rajasekaran, S.
Chan, P-L.
Swaminathan, S.
Dewan, P. K.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (05) : 573 - 578
[39] Analysis of Drug Resistance Characteristics of Mycobacterium Tuberculosis in Anhui Province, 2016-2022
Bao, Xundi
Liang, Shuo
Li, Jun
Ye, Qian
Wu, Dandan
Wang, Shu
Li, Yue
Ding, Yunsheng
Liu, Jie
INFECTION AND DRUG RESISTANCE, 2024, 17 : 2485 - 2499
[40] Breakthrough TB among people living with HIV on TB preventive therapy
Nyangu, S.
Kagujje, M.
Mwaba, I.
Luhanga, D.
Hambwalula, R.
Maliko, S.
Mushili, T.
Mwamba, E.
Mulai, Mukaba
Muyoyeta, Monde
PUBLIC HEALTH ACTION, 2022, 12 (04): : 153 - 158

← 1 2 3 4 5 →